18546611000001106: Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Betaxolol\Product containing only betaxolol in ocular dose form (medicinal product form)\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Betaxolol\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\UK product\Trade family\Betoptic\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing beta-1 adrenergic receptor antagonist\Product containing betaxolol\Betaxolol\Product containing only betaxolol in ocular dose form (medicinal product form)\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing beta-1 adrenergic receptor antagonist\Product containing betaxolol\Betaxolol\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing beta-1 adrenergic receptor antagonist\Product containing betaxolol\Product containing betaxolol in ocular dose form (medicinal product form)\Product containing only betaxolol in ocular dose form (medicinal product form)\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing betaxolol\Betaxolol\Product containing only betaxolol in ocular dose form (medicinal product form)\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing betaxolol\Betaxolol\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing betaxolol\Product containing betaxolol in ocular dose form (medicinal product form)\Product containing only betaxolol in ocular dose form (medicinal product form)\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing betaxolol\Betaxolol\Product containing only betaxolol in ocular dose form (medicinal product form)\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing betaxolol\Betaxolol\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing betaxolol\Product containing betaxolol in ocular dose form (medicinal product form)\Product containing only betaxolol in ocular dose form (medicinal product form)\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiglaucoma agent (product)\Product containing betaxolol in ocular dose form (medicinal product form)\Product containing only betaxolol in ocular dose form (medicinal product form)\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as ocular dose form\Product containing betaxolol in ocular dose form (medicinal product form)\Product containing only betaxolol in ocular dose form (medicinal product form)\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing beta-1 adrenergic receptor antagonist\Product containing betaxolol\Betaxolol\Product containing only betaxolol in ocular dose form (medicinal product form)\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing beta-1 adrenergic receptor antagonist\Product containing betaxolol\Betaxolol\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing beta-1 adrenergic receptor antagonist\Product containing betaxolol\Product containing betaxolol in ocular dose form (medicinal product form)\Product containing only betaxolol in ocular dose form (medicinal product form)\Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops\Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Mar 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

63635001000001111 Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

78160801000001116 Betoptic 0.25% suspension eye drops (DE Pharmaceuticals) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel Import - supplier (qualifier value)	false	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel import	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has unit of administration	drop	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Is a	Product containing precisely betaxolol (as betaxolol hydrochloride) 2.5 milligram/1 milliliter conventional release eye drops	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has active ingredient	Betaxolol hydrochloride	false	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release eye drops	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has specific active ingredient	Betaxolol hydrochloride	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has dispensed dose form	Conventional release eye drops	false	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has dispensed dose form	Drops dose form	false	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Betaxolol	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Is a	Betoptic	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has dispensed dose form	Conventional release eye drops	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has basis of strength substance	Betaxolol	true	Inferred relationship	Existential restriction modifier
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Has unit of administration	drop	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd) 5 ml	Has AMP	True	Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
63635001000001111	Betoptic 0.25% suspension eye drops (Doncaster Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
78160801000001116	Betoptic 0.25% suspension eye drops (DE Pharmaceuticals)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module